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Background 
 
Upper GI Bleeding is a medical and surgical mortality rate accounts to 10%. 
Most of the patients presents to hospital in hypovolemia and shock. Considering 
all these, this study on 50 patients presented with upper GI bleeding admitted in 
our hospital, GMKMCH, Salem enabled us to identify commonest etiology, 
clinical presentation and prognosis in the locality. 
 
Methodology 
 
The cases were evaluated through proper history taking, thorough clinical 
examination, endoscopic examination and were grouped under seven groups 
and were analyzed. Patients less than 15 years and patients not stabilized within 
48 hours of resuscitation were excluded from the study. 
 
Observation 
 
Duodenal ulcer was the commonest cause of upper GI bleed (37%) followed by 
esophageal varices (20%). Peak incidence was among 35 – 45 years with male 
predominance. Most patients presented with both hematemesis and malena 
(52%). Patients were treated with PPIs, sclerotherapy (10) or banding (9). 
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Conclusion 
 
Peptic ulcer is the commonest cause. Sex and blood group distribution were 
similar to other studies. Death due to upper GI bleed is still a challenge for the 
investigators too. 
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INTRODUCTION 
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Upper GI Bleeding is a medical and surgical emergency. Most commonly 
patients presents with hematemesis and malena. (1) Upper GI Bleeding denotes 
bleeding above the ligament of Treitz. Malena is foul smelling tarry stools due 
to altered blood. (2) 50 to 100 ml of blood loss is required to produce malena. 
 
Mortality from bleeding increases with age. (3) Overall mortality accounts to 
10%. (2) Mortality in less than 60 years without co-morbidities like malignancy 
or organ failure accounts to less than 1%. Mortality from first bleed from 
varices is 50%. (4) Inpatient mortality due to rebleeding amounts to 30%. (5) 
 
The best investigation in upper GI bleed is upper GI endoscopy. It enables 
diagnosis appropriate therapy and prognostic significance. (5) 
 
With diverse etiology and fatal outcome all cases of recent GI bleed should be 
admitted and evaluated and treated accordingly. When patient is in shock or 
when haemoglobin is less than 10g/ml, patient should be stabilized and 
subjected for OGD scopy to identify the cause for prompt management. 
 
Considering all these factors, this study on 50 patients presented with upper GI 
bleed admitted in our hospital, GMKMCH, Salem, enabled to identify most 
common etiology clinical presentation and prognosis in the locality and will 
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help create awareness among all levels of Medical practitioners and enhance 
prompt diagnosis and at least early referral. 
 
This helps reducing suffering and cost of expensive investigations for the poor 
patients in this locality.  
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AIM OF THE STUDY 
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1. To assess the clinical status of the patient getting admitted. 
 
2. Work up including OGD Scopy. 
 
3. To analyse the cause. 
 
4. To analyse the different Management modalities. 
 
5. To find the period of hospital stay. 
 
6. To analyse the outcome. 
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HISTORICAL REVIEW 
 
1. Vaclav Treitz first described the “Ligament of Treitz” also known as 
suspensory muscle of duodenum in 1853. 
 
2. Ryles tube was first introduced in clinical practice by Abraham Louis 
Levin in 1927 
 
3. Helico bacter pylori as a cause of peptic ulcer was first identified in1983 
by Dr.barry J.Marshall and Dr.J.Robin warren at Perth 
 
4. SengstakenBlakemore tube was introduced by Robert Sengstaken and 
Arthur Hendley Blakemore in 1950 
 
5. Octreotide first synthesized in 1979 by chemist Wilfried Bauer 
 
6. Mallory Weiss tear first identified by G.Kenneth Mallory and Soma 
Weiss in 1929 
 
7. Rockall scoring system was introduced by Prof.Tim Rockall  in 1996 
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8. Basil Hischowitz and Larry Curtiss invented first fibre optic endoscope 
in 1957 
 
9. Sclerotherapy  was first introduced by D.Zollikofer in Switzerland in 
1982 
 
10. Banding  techniques was first introduced by Wilkinson and peloso in 
1978 
 
11. TIPS  procedure was first described by Josef Rosch in 1969  
 
 
 
 
 
 
 
 
 
 
 ANATOMY OF STOMACH
 
The stomach is the first intra
digestive, tract. It is a muscular, highly vascular
cardiaca gastri) is the acute angle between the abdominal esophagus and the 
fundus of the stomach, which is the part of stomach above a horizontal line 
drawn from the cardia. The body (corpus) of the stomach leads to the pyloric 
antrum (at the incisura angularis). 
to become the pyloric canal, surrounded by the pyloric sphincter, which joins 
the duodenum at the L1 level (transpyloric plane) to the right of the midline
 
 
FIG 1.PARTS OF STOMACH
 
The celiac trunk (axis) arises from the anterior surface of the abdominal aorta at 
the level of L1. It has a short length (about 1 cm) and trifurcates into the 
ACUTE UPPER GASTRO INTESTINAL BLEEDING 
 
-abdominal part of the gastrointestinal (GI), or 
. The cardiac notch (incisura 
The pyloric antrum narrows toward the right 
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 common hepatic artery (CHA), the splenic artery, and the left gastric artery 
(LGA). 
FIG 2: BLOOD SUPPLY OF STOMACH
 
The LGA runs toward the lesser curvature of the stomach and divides into an 
ascending branch (supplying the abdominal esophagus) and a descending 
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branch (supplying the stomach). The CHA runs toward the right on the superior 
border of the pancreas and gives off the gastroduodenal artery (GDA), which 
runs down behind the first part of the duodenum. After giving off the GDA, the 
CHA continues as the proper hepatic artery. 
 
The right gastric artery, a branch from the proper hepatic artery, travels along 
the lesser curvature from right to left and joins the descending branch of the 
LGA to form an arcade along the lesser curvature between the 2 leaves of 
peritoneum of the lesser omentum. This arcade gives off multiple small arteries 
to the body of the stomach. The GDA divides into the right gastro-omental 
(gastroepiploic) artery (RGEA) and the anterior superior pancreaticoduodenal 
artery (SPDA); it also gives off the small supraduodenal artery (of Wilkie). The 
RGEA runs along the greater curvature from right to left. 
 
The splenic artery runs toward the left on the superior border of the distal body 
and tail of pancreas and gives off the left gastro-omental artery (LGEA), which 
runs from left to right along the greater curvature and joins the RGEA to form 
an arcade along the greater curvature between the two leaves of peritoneum of 
the greater omentum. 
 
The greater curvature arcade formed by the RGEA and the LGEA provides 
several omental (epiploic) branches to supply the highly vascular greater 
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omentum. The splenic artery also gives off 3-5 short gastric arteries that run in 
the gastrosplenic ligament and supply the upper part of the greater curvature and 
the gastric fundus. The stomach has a rich network of vessels in its submucosa. 
The left gastric (coronary) vein drains into the portal vein at its formation (by 
the union of the splenic and superior mesenteric veins). The right gastric and 
right gastro-omental veins drain into the portal vein. The left gastro-omental 
vein drains into the splenic vein, as do the short gastric veins. 
 
The pylorus is marked by an angular or prepyloric vein (of Mayo), which lies 
along the incisura angularis. The gastrocolic trunk is present in a large number 
of cases and lies at the junction of the small bowel mesentery and the transverse 
mesocolon. It may drain the right colic, middle colic, and right gastro-omental 
veins. 
 
The short gastric arteries and veins are sometimes collectively referred to as the 
vasa brevia. 
 
KNOWLEDGE ABOUT UPPER GI BLEEDING 
 
Haemorrhage 
Most patients with hematemesis and malena present in the hospital as primary 
bleeder while some patients (secondary bleeders) who are critically ill develop 
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hematemesis and malena in the hospital. The mortality is very high in patient 
with bleeding that develops in the hospital and this is usually a result of 
systemic diseases. (6) 
 
Hematemesis means the vomiting of fresh blood, blood with clots, or blood 
which has been subjected to digestion by gastric juices. 
  
Malena is the term used to describe passage of black tarry stool containing 
altered blood; this is usually due to bleeding from upper GI tract, although 
haemorrhage from the right side of the colon is occasionally responsible. 
Stools are tarrying (“sticky”) and have a characteristic odour. (7) 
  
Factors responsible for tarry stools are: 
1. Site of bleeding 
2. Amount of bleeding 
3. Rapidity of bleeding 
4. Intestinal transit time 
5. Bacterial breakdown of haemoglobin in the intestine. 
 
Haematochezia is the passage of bright red blood per rectum, generally signifies 
bleeding from a source distal to the ligament of treitz. However, brisk proximal 
bleeding can cause haematochezia due to rapid transit. 
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ETIOLOGY OF UPPER GI BLEED: 
 
Most common presentation is hematemesis and malena. Common causes 
include: 
 
1. Peptic Ulcer - Duodenal Ulcer And Gastric Ulcer 
2. Erosive Gastritis 
3. Variceal Bleed – Portal Hypertention 
4. Reflux Esophagitis 
5. Mallory – Weiss Tear 
6. Vascular Malformation 
 
Uncommon causes include: 
 
1. Gastric carcinoma-lymphoma, polyps 
2. Duodenal or jejunal diverticuli 
3. Aorto duodenal fistulas 
4. Primary aorto esophageal fistula 
5. Blood dyscrasias 
6. Vasculitis 
7. Hemorrhagic telangiectasia 
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8. Connective tissue disorder 
9. Uremia 
10. Undoubtful sources 
 
In a study conducted in 1534 patients in Greece with upper GI bleeding, it was 
found that peptic ulcer (67%) is the most common cause. (8) 
 
In a study conducted in 5000 patients in Thailand, it was evident that peptic 
ulcer contributed 51.24%. 
 
In National American Society of Gastroenterology (ASGE) survey on upper 
GIT on 2225 patients, duodenal & gastric ulcer were the commonest cause of 
upper GI bleeding. (9) 
 
In recent years, UGI bleeding has been associated with the ingestion of NSAIDs 
for arthritis about 35% patients with GI bleeding gives history of consuming 
NSAIDSs a week prior to presentation. Majority of them were above  60 years. 
(10)
 
 
In a study in Somerville K20 shows that 35-55% of elderly patients admitted 
with upper GI bleeding has taken NSAIDS with 10% mortality. Vascular 
anamolies like vascular ectasias contribute to 7%. 
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PATHOPHYSIOLOGY 
 
Variety of factors contributes to the development of peptic ulcer disease. Final 
common pathway to ulcer formation is acid – peptic injury of gastroduodenal 
mucosal barrier. The adage “No acid - No ulcer” remains true even today. (11) 
 
Duodenal ulcer has typically been viewed as a disease of increased acid peptic 
action on the duodenal mucosa, whereas gastric ulcer disease of weakened 
mucosal defenses even with decreased acid – peptic activity. 
 
Peptic ulcer mainly due to imbalance between the aggression, defence and 
repair factors. (13)  
 
A. Aggression Factors 
i. Acid 
ii. Pepsin 
iii. NSAIDS 
iv. H.pylori 
 
B. Defense Factors 
i. Bicarbonate 
ii. Blood flow 
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iii. Mucous 
iv. Cell junction 
v. Apical resistance 
 
C. Repair Mechanism 
i. Restitution 
ii. Mucoid Cap 
iii. Proliferation 
iv. Growth Factors 
 
Acid Secretion and Peptic Ulcer 
 
Duodenal Ulcer patients have higher mean basal acid output (BAO) and higher 
mean acid output (MAO) compared to normal controls. Nocturnal acid secretion 
in increased than day time secretion. The patients have exaggerated response to 
any gastric acid stimulus. The patients also have increased parietal cell response 
to gastrin. (11) 
 
Factors responsible for duodenal ulcers are: (12) 
i. Increased Basal Acid Output 
ii. Increased Gastric acid response to gastrin 
iii. Impaired feedback mechanism 
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iv. Increased rate of gastric emptying 
v. Increased acid load to the duodenum at any given time 
vi. Decreased duodenal bicarbonate secretion and buffering capacity 
 
Factors responsible for gastric ulcers are: 
i. Weak mucosal defenses 
ii. Duodeno gastric reflex  
iii. NSAIDS  
iv. H.pylori 
v. Chronic gastritis 
vi. Aspirin 
 
Gastric ulcers are due to weak mucosal defenses that permit abnormal amount 
of injurious acid, back diffusion into the mucosa. Duodeno gastric reflex causes 
reflex of bile, lysolecithin, pancreatic juice which are injurious to gastric 
mucosa. 
 
Types of Gastric Ulcer 
 
Johnsons Classification: (11) 
Type 1 – ulcer near angularis incisura with normal or decreased acid production 
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Type II – active or quiescent duodenal ulcer with normal or increased acid 
secretion 
Type III – prepyloric ulcer with normal or increased acid secretion 
Type IV – ulcer at gastroesophageal junction with normal or decreased acid 
secretion 
Type V – ulcer anywhere associated with medications 
 
Helicobacter Pylori and Peptic Ulcer Disease 
 
Patients with H.Pylori induced antral gastritis are 3 ½ times more likely to 
develop PUD than the patients without H.Pylori infection. 90% of Duodenal 
Ulcer and 70%-90%of Gastric Ulcer has H.Pylori infection. It causes hyper 
gastrenemia and acid hyper secretion which results in antral gastritis and antral 
epithelial metaplasia in post Pyloric duodenum. 
 
NSAIDS in Peptic Ulcer Disease 
 
Patients with rheumatoid arthritis or osteoarthritis on NSAIDS have 15-20% 
annual incidents of peptic ulcer disease. Prevalence of peptic ulcer disease in 
chronic NSAID users is 25%. There is an extra 5% increase in risk in patients 
above 60 years.  
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Factors that increase the risk of NSAIDS induced peptic ulcer disease are: 
1) Age more than 60 years 
2) Prior gastro intestinal events 
3) High NSAIDS dosage 
4) Concurrent steroid intake 
5) Concurrent anticoagulant therapy 
 
Smoking Induced Peptic Ulcer 
 
Smokers are about twice as likely to develop PUD when compared to non-
smokers because smoking causes(12) 
1) Increased gastric acid secretion 
2) Duodeno gastric reflux 
3) Decreases gastroduodenal prostaglandin production 
4) Decreases pancreatico duodenal bicarbonate production 
 
Alcohol and Peptic Ulcer Disease (11) 
 
Alcohol is being commonly mentioned as a risk factor. Confirmatory data are 
lacking. Hudson proposed possibility of alcohol causing erosive mucosal 
disease. 
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Stress and Peptic Ulcer (12) 
 
Cushing described acute peptic ulcer in patients in head trauma. 
Curlings described duodenal ulcer/duodenitis in burns patients. 
 
Other causes of Peptic Ulcer disease includes (14) 
1) Gastrinoma / MEN Type 1 Syndrome 
2) Chronic Obstructive Pulmonary Disease 
3) Chronic Renal Failure 
4) Cirrhosis Liver 
5) Systemic Mastocytosis  
 
Erosive gastritis (12)  
 
It denotes mucosal inflammation. Erosion is mere shedding of superficial 
epithelium of stomach and occasionally of duodenum. The causes include: (12) 
1) H.Pylori 
2) Alcohol 
3) NSAIDS 
4) Crohns Disease 
5) Tuberculosis 
6) Bile reflux  
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The above factors cause mucosal damage by immune cell infiltration and 
cytokine production. Alchohol, aspirin and bile additionally causes mucosal 
damage by back diffusion of Luminal hydrogen ions. 
 
Stress Induced Gastritis (12) 
 
Gastritis due to stress is on the decline now due to better critical care with acid 
suppression and cytoprotective drugs. Stress induced gastritis caused due to 
inadequate gastric mucosal blood flow. Causes include: 
1) Shock 
2) Burns 
3) Sepsis 
4) Severe trauma and head injury 
 
Features of Gastric Erosion (15) 
 
1) Ulcer less than 1 cm diameter  
2) Rarely penetrates mucosa. 
3) Absence of scarring or thickening of blood vessels  
4) Heals with complete epithelisation  
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Recurrent ulcer (16) 
 
Recurrent ulcer occurs in approximately 5% of all patients after surgery for 
peptic ulcer. Risk of recurrence is 3 to 10% after surgery for duodenal ulcer and 
2% after gastric ulcer surgery. Causes include: 
1) Inadequate surgical procedure 
2) Zollinger Ellison syndrome 
3) Gastric/duodenal carcinoma 
4) Persistent H.pylori infection 
5) Non compliant patient to drugs 
6) Motility disorder 
 
Isolated gastric varices (12) 
 
It occurs in absence of esophageal varices. It includes two types. 
Type 1- Fundic Varices 
Type 2- Distal to Fundus (including proximal duodenum) 
 
The commonest causes include portal hypertension and splenic vein thrombosis. 
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Mallory Weiss Tear (12) 
 
Mallory Weiss Tear is a longitudinal tear in the mucosa of the gastro esophageal 
junction presumably caused by forceful vomiting or retching. It is commonly 
seen in alcoholics. Patients present with hematemesis. 90% of patients stop 
bleeding spontaneously.  
 
Esophageal varices 
 
Varices are tortuous veins within the submucosa of distal esophagus and 
proximal stomach. Esophageal varices are mainly supplied by left gastric vein 
and gastric varices are mainly supplied by short gastric veins. (17) 
 
Bleeding from varices may occur when portal pressure exceeds 11 to 12 mm of 
Hg above the IVC pressure. Esophageal varices are a common cause of 
bleeding with a mortality of 50%. (18) Most survivors rebleed with an impatient 
mortality of 30%. 
 
Watermelon Stomach (12) 
 
It is a gastric antral vascular ectasia. It is characterized by dilated mucosal blood 
vessels in the lamina propria. It is associated with mucosal fibro muscular 
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hyperplasia and hyalinization. It differs from portal hypertensive gastropathy by 
preferentially affecting the distal stomach.  
 
Dieulafoy’s Lesions (11) 
 
Congenital arterio venous malformation is characterized by unusual large 
tortuous submucosal arteries. If these arteries get eroded pulsatile bleeding may 
occur. It typically occurs in middle aged and elderly men. Patients present with 
upper GI bleeding. Intermittent endoscopy can miss the lesion.   
 
Investigations: 
1. Blood grouping and typing for purposes of blood transfusion if any 
 
2.  Haemoglobin Percentage: 
• Initial haemoglobin will be baseline because patient is losing whole 
blood. 
• Later due to influence of extra vascular fluid and fluid for 
resuscitation haemoglobin declines as blood dilutes. Blood 
haemoglobin is to be monitored every six hours. 
 
3. Total count increases after haemorrhage. 
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4. Neutrophilic picture in the differential count 
 
5. Platelet count increases after haemorrhage 
 
6. Bleeding, clotting and prothrombin times are assessed to rule out blood 
dyscrsias. 
 
7. Blood urea, nitrogen increased in upper GI bleed as blood gets absorbed as it 
passes down the GIT and also as a result of impaired renal perfusion. 
 
8. Liver Function Test 
Bilirubin and liver enzymes like SGOT, SGPT are raised in case of liver disease 
as a cause of Upper GI Bleed. 
Prothrombin time is increased in chronic liver disease and in patients on oral 
anti coagulants. 
 
9. Viral markers. HBsAg, Anti HVC, HBcAg 
 
10. Ultra Sonogram Abdomen 
• To assess the hepatic echo texture in case of chronic liver disease and 
to study portal vein. 
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11. Nasogastric Aspiration 
• To assess whether a patient has ongoing bleeding or not and might be 
benefitted from an early endoscopy. 
• Nasogastric lavage helps to remove clots, blood, and debris from 
stomach to aid endoscopy and also to assess the rapidity of bleeding. 
 
UPPER GI ENDOSCOPY 
 
Upper GI Endoscopy is the diagnostic modality of choice for an acute upper GI 
bleeding. (19,44) 
 
Endoscopy has a high sensitivity and specificity for lesion identification. It has 
both diagnostic and therapeutic advantage by identifying the site of bleeding 
and ensuring haemostasis. (45) 
 
Early endoscopy (i.e.) within 24 hours is recommended for acute upper GI 
bleeding which delineates. 
a. Site of bleeding  
b. Rapidity of bleeding (i.e.) spurting or oozing 
c. Any stigmata of recent haemorrhage 
d. Assessing associated lesions 
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Indications: 
1. Any patients with acute upper GI bleeding 
2. To assess the site of bleeding 
3. When surgery is contemplated 
4. Rebleeding 
5. Therapeutic purpose. Sclerotherapy, banding, electro coagulation 
 
Contra Indications for Upper GI endoscopy 
1. Patient non cooperativeness 
2. Shock 
3. Zenker’s diverticulum 
4. Comatosed patients 
5. Suspected perforation 
6. Cardiac decompensation 
7. Acute rmyocardial infarction 
8. Previous oro pharyngeal surgery (or) radiation therapy 
9. Bleeding dyscrasias 
10. Poor general condition 
 
Complications 
1. Perforation 
2. Cardio vascular decompromise 
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3. Aspiration pneumonitis 
4. Bleeding 
5. Infection 
 
RISK STRATIFICATION 
 
Several investigations have developed decision and predictive models that 
permit identifications of patients at low risk of recurrent haemorrhage. Such 
patients can be discharged at the earliest thereby reducing the resource 
utilisation prioritizing the cases as risk and delineates patients who require 
intensive care. 
 
Blotch ford score (20) 
Variables 1 2 3 4 5 6 
Systolic bp 
(mmHg) 100-109 90-99 <90 - - - 
Blood Urea 
Nitrogen 
(mg/dl) 
- 
39.0 -> 
47.4 
48 – 0 - 
59.4 
60.0 -> 
149.4 
- > 150 
Haemoglobin 
(g/dl) 12 – 12.9 - 10 – 11.9 - - < 10 
Others Heart Rate > 
100 
 
Malena 
Hepatic 
Disorder 
 
Cardiac 
Failure 
- - - - 
TABLE 1: Blotch ford scoring SYSTEM IN UPPER GI BLEED. 
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Scoring system ranges from 0 to 23 and the risk of requiring endoscopic 
intervention increases with increase in the score. (20) 
 
AIMS 65 SCORE: 
It is another scoring system that utilizes data available prior to endoscopy. It has 
high accuracy for predicting inpatient mortality among patient with upper GI 
bleeding. (21) 
 
The scoring system includes five factors that are associated with increased 
inpatients mortality. 
 
i. Albumin less than 3 g/dl 
ii. INR > 1.5 
iii. Altered mental status (GCS < 14) 
iv. Systolic blood pressure ≤ 90 mmHg 
v. Age > 65 years 
 
The mortality rate increases as the number of factors increases. It also predicts 
duration of hospital stay but could not assess rebleeding. (43) 
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Rockall Score (22) 
 
2008 Scottish Intercollegiate Guidelines Network (SIGN) guideline on the 
Management of acute upper GI bleed to which recommends that an initial (pre 
endoscopic) Rockall Score be calculator for all patients presenting with acute 
UGIB in patients with an initial Rockall Score less than zero. 
 
It is a useful system to access UGIB. The Rockall system is an accurate and 
valid predictor of rebleeding and death. 
 
It is a summation of point grading system assigned to each of the components 
bounded on a scale of 0 to 11. 
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The Rockall Scoring System (23) 
 SCORE 
Variable 0 1 2 3 
Age (Years) < 60 60 - 79 ≥ 80  
 
 
 
 
Shock 
 
 
 
 
No Shock 
Systolic 
BP > 100 mm 
Hg 
 
HR < 100 
bt/min 
Tachycardia 
systolic BP > 
100 
 
HR > 100 
bt/min 
Hypotension 
systolic BP < 
100/min 
 
 
 
 
 
 
 
 
 
Comorbidity Nil  
Cardiac 
failure 
Ischemic 
heart disease 
or any others. 
Renal failure, 
Liver failure. 
Disseminated 
malignancy 
Diagnosis 
Mallory-
Weiss tear 
 
No Lesion 
 
No SRH 
All other 
diagnosis 
Malignancy 
of Upper GI 
tract 
 
Major SRH None (or) 
Dark spot 
 
Blood in 
Upper GI 
tract adherent 
clot spurting 
vessel 
 
TABLE 2: ROCKALL SCORING SYSTEM. 
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A score of 0 – 3 is grouped under low risk and 3 – 5 as Moderate Risk and > 5 
are high risk groups. 
 
MANAGEMENT OF UPPER GI BLEEDING 
 
Objectives in the Management Of Upper GI Bleeding 
 
• Immediate clinical status assessment 
• Stabilize the hemodynamic status 
• Identify the source of bleeding 
• Stopping the active bleeding 
• Treat the underlying cause 
• Prevent recurrent bleeding 
 
General Management 
 
All patients with hemodynamic instability (shock, orthostatic hypotension) or 
active bleeding (i.e.) hematemesis, (or) bright red blood through the naso gastric 
tube should be admitted in an Intensive Care Unit for resuscitation and close 
monitoring. 
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Other patients with upper GI bleed with stable vitals and hemodynamic status 
and no further bouts of hematemesis can be admitted in routine surgical ward. 
 
General Support 
 
Patient should be kept Nil per oral. Oxygen support given by nasal canula. Two 
large calibre peripheral intra venous catheter or central venous line should be 
placed. Elective endo tracheal intubation if patient has altered neurological 
status which may facilitate, during endoscopy and may prevent aspiration of 
Gastric contents. 
 
Fluid Resuscitation 
 
Prior to endoscopy, stabilization and resuscitation of the patient is a must to 
minimize the treatment associated complications. 
Crystalloids and colloids administered to restore the blood pressure if 
hypoalbuminemia is detected, cross match blood and sent blood sample for 
haemoglobin, haematocrit, BUN. (24) 
Monitor urine output, oxygen saturation. 
Place patient In trendelenberg position to maintain cerebral blood flow. (25) 
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Blood Transfusion 
 
The decision to initiate blood transfusions must be individualized. 
Haematocrit is maintained around 30%in elderly with associated co-morbidities 
such as congestive heart failure, chronic renal failure, Ischemic heart disease 
etc. 
 
Haematocrit to be maintained 20-25% in young patients and about 25-28% in 
cases with portal hypertension. 
 
However patients with active bleeding and hypovolemia may require blood 
transfusion despite apparently normal haemoglobin. 
 
Avoid over transfusion in suspected variceal bleeding as it can worse the 
bleeding. 
 
Patients with active bleeding with prolonged prothrombin time and INR > 1.5 
should be corrected with fresh frozen plasma. If INR ≥ 3, it is to be corrected to 
less than 3 prior endoscopy.(26) 
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Platelet transfusion is considered if patient has ongoing bleed with platelet 
count < 50,000 cells/cu.mm and also in patients on oral anti coagulant and anti 
platelet agents. (27) 
 
Gastric Lavage 
 
It is performed in the view to remove blood clots, within the stomach and to 
reduce the rate of blood loss. It has been shown that gastric lavage can cause 
temporary cessation of bleeding in most of patients, regardless of cause of 
bleeding. Experimental evidence suggests that room temperature tap water 
lavage is as effective as ice cold saline lavage. 
 
Drug therapy 
Acid suppression 
Proton Pump Inhibitors 
Patients admitted with acute upper GI bleeding are typically treated with proton 
pump inhibitors (PPI). 
 
High dose anti secretory therapy with an intravenous infusion of a PPI 
significantly reduces the rate of rebleeding and also decreases the length of 
hospital stay. (28) 
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According to 2008 SIGN Guidelines, it recommends that high dose of 
intravenous PPIs in patient with major peptic ulcer bleeding or non-bleeding 
visible vessels after endoscopic bleeding control. PPIs have the ability to 
maintain a gastric Ph at a level above 6.0 and prevents ulcer clot from 
fibrinolysis. 
 
Lao et al demonstrated high dose of intravenous omeprazole can accelerate the 
resolution of stigmata of recent hemorrhage and reduce the need for endoscopic 
therapy. 
 
2010 international consensus guidelines on UGIB recommends use of 
intravenous PPIs in all patients with high risk lesion post endoscopy theory. 
 
The goal of treatment directed at healing the ulcer and eliminating precipitating 
factor and also prevents risk of rebleeding. 
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Diagnostic Approach 
 
History: 
UGIB is a medical and surgical emergency which requires early detection and 
appropriate management. Most common presentation is hematemesis (40 – 
50%) and Malena (70 – 80%). 
 
Other history at presentation includes weakness, dizziness, syncope, 
dyspepsia,sweating, early satiety history of analgesic intake. 
 
History of chronic alcohol intake or chronic hepatitis B or C infection suggests 
possibility of variceal haemorrhage or portal gastropathy. 
 
History of Epigastric pain and antacid intake related to peptic ulcer disease.  
 
History of dyspepsia, early satiety, NSAID Consumption indicate NSAID 
gastropathy induced UGIB due to poor platelet aggregation. History of lethargy, 
cachexia, loss of weight with epigastric discomfort suggest possibility of 
carcinoma stomach. 
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History of jaundice, abdominal distention, Pedal edema suggest variceal 
bleeding due to cirrhosis. Dysphagia and discomfort during swallowing suggest 
esophageal pathology. 
 
Odynophagia, gastro esophageal reflux, dysphagia suggest possibility of 
esophageal ulcer. 
 
Emesis, retching or coughing are associated with Mallory Weiss tear. 
 
History of burns, cerebral vascular disease, head injury, poly trauma suggest 
possibility of stress ulcer induced UGI Bleeding. 
 
Past History 
 
In case of upper GI bleeding, up to 60% of the patients bleed from the same 
lesions. (29) History of alcohol abuse and liver disorder are associated with 
varices, portal hypertensive gastropathy. In case of peptic ulcer disease, 
bleeding is due to H.Pylori infection, NSAID use and smoking. 
 
Co morbid illnesses like coronary artery disease, pulmonary disorder are more 
susceptible to hypoxemia. Renal and cardiac failure predisposed to volume 
overload and such patients need invasive monitoring during resuscitation. 
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Bleeding due to coagulopathies, thrombocytopenia, and hepatic dysfunction are 
difficult to control such patients need fresh frozen plasma transfusion. 
 
Physical Examination 
 
Physical examination should focus on signs that include the severity of blood 
loss and helps to localize the source of bleeding. 
 
Physical examination is to assess the general condition of the patient and to 
assess the signs of shock, hypovolemia which include high pulse rate, low pulse 
volume,low oxygen saturation, orthostatic hypotension and pallor. 
 
Resting tachycardia indicates mild to moderate hypovolemia. 
Orthostatic hypotension indicates up to 15% blood loss.  
Supine hypotension indicates about 40% blood loss(30). 
 
If there is abdominal pain which is severe and associated with guarding and 
rigidity, perforation should be ruled out prior to endoscopy. Signs of chronic 
liver disease indicates bleeding likely of variceal source which is due to portal 
hypertension and high mortality is expected. 
 
Palpable epigastric mass, virchow’s node is suspicious of gastric carcinoma. 
ACUTE UPPER GASTRO INTESTINAL BLEEDING  
 
 
54 
 
Purpura, splenomegaly, enlarged lymph nodes denote the possibility of blood 
dyscrasias. 
 
Stool colour provide clue to the location of bleeding. Black tarry stools denote 
upper GI bleeding. 
 
Prokinetic Drugs 
 
Both Erythromycin and metoclopramide have been studied in patients with 
acute upper GI bleeding. The goal is to improve gastric visualization at the time 
of endoscopy(31). Erythromycin promotes gastric emptying by acting on motilin 
receptors. 
 
Single dose of erythromycin 3 mg/kg over 20 to 30 minutes, 20 to 120 minutes 
before endoscopy improves visibility, shorten endoscopic time and decrease the 
need for second look endoscopy. 
 
Somatostatin and octreotide 
 
Meta analysis suggest that intravenous administration of somatostatin or its 
long-acting form octreotide decreases the risk of rebleeding from peptic ulcer. 
(32)
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It is mainly used in the treatment of variceal bleeding and may also benefit in 
non variceal causes. 
 
Octreotide is given as an intravenous bolus of 20-50 mcg followed by a 
continuous infusion at a rate of 25 to 50 mcg/hour. (33) 
 
Identification of Bleeding Source 
1. Naso gastric  Aspiration: 
Aspirate may categorize patients as low/intermediate/high risk groups. 
2. Gastric lavage: 
• with saline 
• for better visualization during endoscopy 
• to estimate rapidity of bleeding 
• prevent the development of porto systemic encephalopathy in 
cirrhosis 
• increases the  stomach pH 
 
Endoscopy 
 
Once the patient is hemodynamically stable, endoscopy should be performed to 
identify the source of bleeding. 
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Endoscopy can be of early (< 24 hours) and elective (24 – 48 hours). Former is 
indicated in persistent active bleeding. 
 
Endoscopy offers therapeutic options like glue injections, endo clips 
application, etc. 
 
Treatment of Non Variceal Bleed 
Endoscopic Modalities 
 
a. Injection therapies 
• reduce blood flow by local tamponade 
• use of vaso constricting agents e.g. epinephrine further reduce blood flow 
• 0.5 to 1 ml of 1:20,000 epinephrine by sclerotherapy needle in to four 
quadrants of ulcer within 1 to 2 mm of bleeding site. 
•
 other agents used are fibrin glue, Human thrombin, sclerosants, absolute 
alcohol(23) 
 
b. Contact Thermal Therapy: using heater probes 
 i. Bipolar Cautery 
  -it can be used perpendicularly or tangentially 
  -bleeding vessels are compressed and then coagulated 
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  -10-15 watts in duodenum, 15-20 watts in stomach applied over 8-
12 seconds until the involved vessels flatten out. 
 
Other techniques: 
 ii. Laser photo coagulation 
 iii.  Heater probe method 
 iv.  Gold probe 
 v.  Argon plasma coagulation 
 
Mechanical treatment: 
• Spraying crystalline collagen, clotting factor or cyanoacrylate tissue glue 
to bleeding lesion 
• Application of hemo clips 
• Rebleeding rates are reduced with endo clips. 
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Other techniques: 
 
 
 
Interventional Radiological Procedure 
 
Trans cathetral arterial embolization (34) 
Angiography in patients with ulcer more than 2 cm in association with large 
arteries at the ulcer blood. Also indicated in patients with recurrent bleed 
despite 2 sessions of endoscopic hemostasis. 
 
Surgical treatment 
mechanical 
treatment 
banding
endo 
staples
fibrin glue 
injection
endoloops
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Emergency surgery 
 
Indications for emergency surgery are: 
1. Haemostasis not achieved 
2. Rebleeding in elderly, frail patients 
3. Rebleeding more than once in a young patient 
 
Elective surgery: 
 
1. When patient has bled from the gastric or duodenal ulcer more than one 
occasion 
2. Visible vessel in the base of the ulcer  
3. Bleeding with evidence of gastrinoma 
4. Locally confined bleeding associated with malignant ulcerated mass. (23) 
 
Mallory Weiss syndrome/tear (12) 
 
In about 80-90% of the patients, bleeding stops spontaneously. In about 1 to 5% 
of patients, bleeding recurs. Treatment options include: 
i. endoscopic electro-coagulation of the tear 
ii. angiography therapy with intro arterial infusion of vasopressin or 
embolization 
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iii. operative therapy with over sewing of tear (23) 
 
Erosive gastritis 
 
Erosive Gastritis in sick patients following major surgery, burns, intra cranial 
disease responds to intravenous H2 receptor antagonist. Sucrafate is also 
effective. In case of NSAID induced mucosal injury, the following protocols are 
to be followed. (35) 
 
Clinical Setting Recommendation 
NSAID discontinued H2 Receptor antogram /PPI 
NSAID continued PPI 
Prophylactic therapy Misoproslot; PPI 
H.Pylori infection H.Pylori regimen 
 
Table 3: Treatment options in erosive gastritis 
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Pharmalogical Therapy (35) 
 
Drug Type Examples Dose 
ACID SUPPRESSING DRUGS 
H2 receptor antagonists 
Cimetidine 400 mg bid 
Ranitidine 300 mg hs 
Famotidine 40 mg hs 
Nizatidine 300 mg hs 
PPIs 
Omeprazole 20 mg/d 
Lansoprazole 30 mg/d 
Rabeprazole 20 mg/d 
Pantoprazole 40 mg/d 
Esmoprazole 20 mg/d 
MUCOSAL PROTECTIVE AGENTS 
Sucralfate Sucralfate 1g qid 
Prostaglandin analogue Misoprostal 200µg qid 
Bismuth – containing 
compounds 
BSS  
 
TABLE 4: PHARMACOLOGICAL THERAPY FOR PEPTIC ULCER 
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Regimens for Eradication of H. Pylori Infection in non ulcer dyspepsia(35) 
 
DRUG  DOSE 
Triple Therapy (14 days)   
1. Bismuth Subsalicylate Plus 2 tab. Qid 
- Metronidazole  Plus 250 mg qid 
- Tetracycline  500 mg qid 
2. Ranitidine Bismuth Citrate Plus 400 mg bid 
- Tetracycline Plus 500 mg bid 
- Clarithromycin or 
Metronidazole 
 500 mg bid 
3. Omeprazole Plus 20 mg bid 
- Clarithromycin Plus 250 or 500 mg 
bid 
- Metronidazole Or 500 mg bid 
- Amoxicilline   1 gm bid 
QUADRUPLE THERAPY (7-10 
DAYS) 
  
Omeprazole (Lansoprazole)  20 mg (30 mg) od 
Bismuth Subsalicylate  2 tab. Qid 
Metronidazole  250 mg qid 
Tetracycline   500 mg qid 
 
TABLE 5:H. PYLORI REGIMENS 
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Portal Gastropathy (11) 
 
Treatment options include: 
• Beta adrenergic receptor blockers (propanalol)  
• Surgical porta caval shunt 
• Best treatment option is liver transplantation 
 
Dieulafoy’s Lesion (12) 
 
Endoscopic Doppler ultrasound has been used to identify Dieulafoy’s Lesion. 
The site marked with submucosal ink for future retreatment in case of rebleed. 
Treatment includes injection therapy with thermal probe, clips or band ligation.  
 
Esophagitis (12) 
 
Endoscopic therapy has no role unless a focal ulcer with bleed is visualized. 
Treatment include PPIs to be taken daily for at least 8-12 weeks. Repeat 
endoscopy is to exclude underlying Barrett’s esophagus. 
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Upper GI Malignancy(23) 
 
In case of bleeding malignant ulcers, endoscopic haemostasis with monopolar 
electro cautery, laser, injection therapy, haemoclips can temporarily control 
active bleeding. 
 
Angiography with embolization should be considered for severe UGIB caused 
due to malignancy.  
 
External beam radiation can provide palliative haemostasis in case of advanced 
gastric or duodenal cancer. 
 
Gastric Antral Vascular Ectasia (GAVE) (12) 
 
Endoscopic therapy with argon plasma coagulation has shown 80% effectivity.  
 
Cameron’s Lesions(23) 
 
Long term medical management is usually with iron supplement and oral PPIs 
alleviate the symptoms. 
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Variceal Bleed 
 
 
Medical Management 
Vaso constrictors 
- Vasopresssin  
o 0.1 to 0.5 units per minute for 4 to 12 hours with short acting 
nitrates causes suppression of variceal bleed by vasoconstriction of 
splanchnic vessels whereby decreasing portal venous pressure 
- Terlipressin  
o 2 mg bolus followed by 1 mg every 4 to 6 hourly interval for 3 to 5 
days 
o It is the only drug that has shown increase in survival(36) 
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o Octreotide 50 mcg bolus followed by 50 mcg per hour infusion for 
5 days 
- Somatostatin  
o 250 mcg bolus followed by 250 mcg hourly infusion decreases the 
portal pressure and collaterally blood flow by inhibiting release of 
glucagon(37)  
- Non selective beta blockers  
o It has been used extensively in preventing variceal rebleeding (39) 
o Propanalol (40 mg) and nodalol (20 mg) are preferred drugs that 
are taken once daily  
o  Risk of bleeding is greatest at night and hence beta blockers are 
administered in the evening(40)  
o Patients who do not achieve decrease in the HPVG to less than 12 
mm Hg on beta blockers may not respond to endoscopic variceal 
ligation as well(41) 
o For secondary prophylaxis isosorbide mononitrate may be added to 
a beta blocker(42) 
 
Pressure techniques 
• Sengstaken Blakemore tube 
• Minnesota tube 
• Linton Nicholas tube 
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Balloon should be inflated for at least 24 hours and 75% of patients re-bleed 
after deflation. Balloon tamponade only provides initial control of bleeding in 
85 – 98% of cases. 
 
Major complications following balloon tamponade are 30% rate of aspiration 
pneumonia, esophageal rupture, airway obstruction. Clinical studies do not 
show significant difference in efficacy between the vasopressin and balloon 
tamponade. (38) 
 
Endoscopic Sclerotherapy 
 
Sclerosants can achieve haemostasis in 85-95% cases with rebleeding rate of 
25-30%. 
 
Complications include esophageal ulcer, perforation, esophageal strictures, 
mediastinitis, pleural effusion, aspiration pneumonia. 
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Tissue adhesive glue, N-butryl-2-cyano acrylate preferred in fundal varices. 
 
Banding techniques 
Haemostasis achieved in 80-85% of cases with re bleeding rate of 25-35%. 
Banding techniques are better than sclerotherapy with fewer local 
complications. Banding of varix subsequently undergoes thrombosis ,sloughing, 
fibrosis. 
 
 
 
 
 
sclerosants
sodium 
morrhuate
polidocanol 
3%, 
sodium tetra 
decyl 
sulphate.
ethanolamine
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Surgical Management 
 
 
TIPS 
 
Trans Jugular intra hepatic porto-systemic shunt. 
Connects intrahepatic branch of portal vein to hepatic vein thus reducing portal 
vein pressure gradient to less than 12-15 mm Hg. 
Complications include bleeding, dye induced renal failure, haemolysis, stent 
migration. 
Used to treat complications of portal hypertension mainly: 
i. Refractory variceal bleeding, refractory ascites 
ii. Budd chiari syndrome 
iii. Hepatic hydro thorax 
iv. Hepato renal syndrome 
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MATERIALS AND 
METHODS 
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In this prospective study, cases admitted with upper GI bleed in various surgical 
units, among 50 patients selected randomly, in Government Mohan 
Kumaramangalam Medical College Hospital. The cases were evaluated 
through: 
 
1. Proper history taking 
2. Thorough clinical examination 
3. Endoscopic examination 
4. Other relevant investigations 
5. Outcome at the end of the hospital stay 
 
For the purpose of analysis, the patients with acute upper GI bleeding were 
divided into 7 groups. 
 
1. Duodenal ulcer 
2. Gastric ulcer 
3. Esophageal varices 
4. Gastric erosion 
5. Carcinoma stomach 
6. Miscellanous cause 
7. Source Unknown 
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Miscellaneous group included  
1.esophagitis, 
2.esophageal carcinoma, 
3.telangiectasia, 
4.Mallory Weiss tear. 
 
Patients from both genders were admitted in our hospital with history of 
hematemesis or malena who are hemodynamically stable after resuscitation 
were included in this study.  
 
Exclusion criteria were: 
1. Patients less than 15 years 
2. Patients who were not stabilized within 48 hours of resuscitation 
3. Patients who have contra indications to endoscopy 
4. Patients previously diagnosed to have GI malignancies under treatment 
5. Upper GI bleed due to corrosive poisoning 
6. Upper GI bleed due to medical cause [ bleeding disorder ,drug induced] 
 
A printed proforma, enclosed in Appendix 1, was made to record all 
information collected from the patient and for analysis.  
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OBSERVATION AND 
RESULTS 
 Etiological Pattern of upper G I bleed:
S.No. Etiology
1 Duodenal Ulcer
2 Gastric Ulcer
3 Esophageal varices
4 Gastric Erosion
5 Gastric Carcinoma
6 Miscellaneous
7 Unknown
Table 6: E
Fig 3: E
 
The final diagnosis was made after upper G I endoscopy. 
etiology, peptic ulcer was the commonest cause 
contributed34% followed by variceal bleeding 20%.
20%
10%
4%
10%
6%
Etiological Pattern
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 No. of Patients Percentage
 17 
 8 
 10 
 5 
 2 
 5 
 3 
tiological Pattern of Upper G I Bleed
tiological Pattern of Upper G I Bleed 
Among the various 
(50%). Duodenal ulcer 
 
34%
16%
Duodenal Ulcer
Gastric Ulcer
Esophageal varices
Gastric Erosion
Gastric Carcinoma
Miscellaneous
Unknown
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34 
16 
20 
10 
4 
10 
6 
 
 
 Upper GI Bleed in Relation to 
Age Group
15
25
35
45
55
65
75
Table 7: Upper GI Bleed in Relation to Age
 
Fig.4: Upper GI Bleed in Relation to Age
 
Over all the commonest age  group who suffered from
54 year group (26%).Bleeding due to peptic ulcer was common in younger age 
group,malignancy in elderly age group.
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Age 
 No of Cases Percentage 
-24 4 8 
-34 4 8 
-44 10 20 
-54 13 26 
-64 9 18 
-74 9 18 
-84 1 2 
 
 
 upper GI bleed were 45
 
25-34 35-44 45-54 55-64 65-74 75-84
Age Group
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 Upper GI Bleed in Relation to Gender
Duodenal Ulcer
Gastric Ulcer
Esophageal
Gastric Erosion
Gastric Carcinoma
Miscellaneous
Unknown
Table.8: Upper GI Bleed in Relation to Gender
 
Fig 5: Upper GI Bleed in Relation to Gender
 
Upper GI bleed was common in male (80%)
Male: Female ratio was 4:1.
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Etiology 
Gender 
Male Female 
 15 2 
 6 2 
 varices 8 2 
 4 1 
 1 1 
 3 2 
 3 0 
 
 
. Female contributed 20%.
 
Esophageal 
varices
Gastric 
Erosion
Gastric 
Carcinoma
Miscellaneous Unknown
Etiology
 
 
 
76 
 
 
Male
Female
 Habitat 
Etiology
Duodenal Ulcer
Gastric Ulcer
Esophageal varices
Gastric Erosion
Gastric Carcinoma
Miscellaneous
Unknown
Table 9: Upper GI Bleed in Relation to habitat
 
Fig 6: Upper 
 
Rural population (64%) suffered upper GI bleed more common tha
population (36%). 
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n the urban 
Urban
Rural
 Etiological Agents 
Etiology 
Duodenal Ulcer 
Gastric Ulcer 
Esophageal varices
Gastric Erosion 
Gastric Carcinoma
Miscellaneous 
Unknown 
Table 10: Upper GI Bleed in Relation to etiological agents
Fig 7: Upper
 
Correlation of upper GI bleed with smoking was found 
1(25%) cases of duodenal
NSAIDs were found 8(47%),
erosive gastritis respectively.
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Smoking NSAIDS Steroids Alcohol
11 8 3 
4 3 1 
 4 0 1 
1 4 1 
 1 0 0 
2 1 0 
1 3 0 
 GI Bleed in Relation to etiological agents
11(65%)
 ulcer, gastric ulcer, erosive gastritis respectively. 
 3(38%), 4(80%) of duodenal ulcer, gastric
 
Esophageal 
varices
Gastric Erosion Gastric 
Carcinoma
Miscellaneous
Etiology
Etiological Agents
NSAIDS Steroids Alcohol
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4 
1 
6 
2 
0 
1 
0 
 
 
 
, 4(50%), 
 ulcer, 
Unknown
 Clinical Presentation of the Patients
Symptoms 
No of 
Patients
Duodenal Ulcer 4
Gastric Ulcer 3
Esophageal varices 4
Gastric Erosion 1
Gastric Carcinoma 0
Miscellaneous 2
Unknown 1
Table 11
Fig.8: Clinical Presentation of the Patients
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Hematemesis Malena Hematemesis & 
 
Percentage No of Patients Percentage 
No of 
Patients
 24 3 17 10
 38 1 13 
 40 2 20 
 20 1 20 
 0 1 15 
 40 1 20 
 33 0 0 
: Clinical Presentation of the Patients 
 
 
Esophageal 
varices
Gastric 
Erosion
Gastric 
Carcinoma
Miscellaneous
Malena Hematemesis & Malena
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Malena 
 
Percentage 
 59 
4 50 
4 40 
3 60 
1 50 
2 40 
2 67 
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Hematemesis ,malena and both hematemesis and malena were the presenting 
features of 30%, 18% and 52% of the patients. 
 
Among them 4 (24%) patients of DU, 3 (38%) patients of GU & 4 (40%) 
patients of oesophageal varices presented with hematemesis and 3 (17%) 
patients of DU 1 (13%) patients of GU & 2 (20%) patients of oesophageal 
varices presented with malena 10 (59%) patients of DU presented with 
hematemesis and malena. 
 
Past History 
Etiology 
Epigastric Pain Hematemesis/Malena Jaundice Loss of weight 
No of 
Patients Percentage 
No of 
Patients Percentage 
No of 
Patients Percentage 
No of 
Patients Percentage 
Duodenal Ulcer 15 88 2 12 0 0 2 12 
Gastric Ulcer 6 75 0 0 0 0 6 75 
Esophageal 
varices 2 20 3 30 8 80 5 50 
Gastric Erosion 4 80 0 0 0 0 0 0 
Gastric 
Carcinoma 0 0 0 0 1 50 2 100 
Miscellaneous 1 20 0 0 0 0 0 0 
Unknown 1 33 0 0 0 0 0 0 
Table .12: Upper GI Bleed in Relation to past history 
 
 Fig 9: Upper
 
Past history of epigastria pain was noted 15 (88%) and 6 (75%) cases of 
duodenal ulcer and gastric ulcer patients respectively. Past history of jaundice 
was obtained in 8 (80%) cases with oesophageal varices. Past history of 
hematemesis and malena 
ulcer and oesophagcal varices.
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Unknown
 Correlation with Clinical 
Signs 
Anemia 
Epigastric Tenderness
Splenomegaly
Ascites 
Hepatic Failure
Table.13: Upper
 
Fig 10: Upper GI Bleed in Relation to clinical signs
 
Anemia, epigastric tenderness, splenomegaly were found 
cases respectively. 
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Signs 
No of Patients Percentage
37 74 
 30 60 
 9 18 
10 20 
 9 18 
 GI Bleed in Relation to clinical signs
in 74%, 60% and 18% 
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Hepatic Failure
 Relation with Blood Group
Etiology O
No of 
Patients 
Duodenal Ulcer 8 
Gastric Ulcer 3 
Esophageal varices 5 
Gastric Erosion 2 
Gastric Carcinoma 0 
Miscellaneous 2 
Unknown 2 
Table 14: Upper
Fig 11: Upper
As a whole, patients with 
hematemesis & malena with especially due to duodenal ulcer (47%). 
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Blood Groups 
 A B 
Percentage No of Patients Percentage 
No of 
Patients Percentage
47 1 6 4 24 
38 1 13 2 25 
50 1 10 3 30 
40 1 20 2 40 
0 1 50 0 0 
40 0 0 2 40 
67 0 0 1 33 
 GI Bleed in Relation to blood group
 GI Bleed in Relation to blood group
“O” blood group suffered more 22(44%) from 
Esophageal 
varices
Gastric 
Erosion
Gastric 
Carcinoma
Miscellaneous
O A B AB
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AB 
 
No of 
Patients Percentage 
4 24 
2 25 
1 10 
0 0 
1 50 
1 20 
0 0 
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 Naso Gastric Aspirate 
NGA
Clean
Coffee Ground
Red Blood
Table.1
Fig 12
 
Nasogastric aspiration shows 86
colour of aspirated material which is suggestive for 
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 No of Patients Percentage 
 7 14 
 16 32 
 27 54 
5: Nature of Naso Gastric Aspirate 
 
: Nature of Naso Gastric Aspirate 
% of the patients having fresh or coffee ground 
hematemesis
Clean Coffee Ground Red Blood
NGA
Naso Gastric Aspirate
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Rockall Score Interpretation 
Score No. of Patients Percentage (%) 
Low Risk ( < 3 ) 10 20 
Moderate Risk ( 3 – 5 ) 27 54 
High Risk 13 26 
Table.16: Rockall Score Interpretation 
 
Rockall Scoring and its adverse outcomes 
Variable Low Risk Medium Risk High Risk 
Score 0 - 2 3 - 5 6 – 11 
No. of Patients 10 27 13 
Blood Transfusion 4 16 13 
Re admission - 3 3 
Repeat Endoscopy 1 3 2 
Re bleed 1 7 3 
Death - - 2 
Table.17: Rockall Scoring and its adverse outcomes 
 
Rock all score was calculated and interpreted. Majority of patients 27(54%) 
were in the medium risk category .of which 4(40%), 16(59%), 13(100%) of 
patients belonging to low risk, medium risk, high risk groups required blood 
transfusion.1(10%),7(26%),3(23%) of low risk, medium risk, high risk groups 
had rebleeding. 
 Various Management Modalities
Type of Therapy
Proton Pump Inhibitors
Vasopressin
Octreotide
Sclerotherapy
Banding
Surgery
Table.18
Fig.13
In managing the cases with 
treated with 37 patients (74%) were treated with proton pump
pantoprazole). Among the clinically suspected o
were treated with vasopressin and twelve
treated with banding. Among the end
were treated with sclerotherapy.
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 Total Percentage 
 37 74 
 2 4 
 12 24 
 10 20 
 9 18 
 2 4 
: Various Management Modalities 
: Various Management Modalities 
hematemesis and malena 65 patients (65%) were 
esophageal varices patients two
 were treated with octreo
oscopically diagnosed ulcer
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 Recurrent Bleed 
Etiology Conservative
Duodenal 
Ulcer 
Gastric Ulcer 
Varices 
 
During the hospital stay, 1(5.9%),
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 Sclerotherapy Banding Total Percentage
1 0 0 1 
1 0 0 1 
1 1 1 3 
Table.19: Recurrent Bleed 
 
Fig.14: Recurrent Bleed 
 1(2.5%), 3(30%) of duodenal 
recurrent bleed. 
Gastric Ulcer Varices
Recurrant Bleed
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No of 
Cases 
Mean Stay 
(days) 
 17 5 
 8 4 
 10 9 
 5 3 
 2 9 
 5 5 
 3 2 
Table.20: Mean hospital stay 
Fig 15: Mean hospital stay 
days, gastric ulcer was 4 days and 
 9 days. 
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 Outcome 
Etiology
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Overall mortality due to Upper GI Bleed is 
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 Recovered Expired Mortality 
16 1 5.9% 
 10 1 10% 
Table.21:Patient outcome 
Fig 16: Patient outcome 
4% of which duodenal ulcer 
had1 (10%) mortality rate. 
Varices
Outcome
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In this study, the mean age of the patients presented with upper GI bleeding was 
44.56 and was 49.82 years for duodenal ulcer and 52.25 years for gastric 
ulcers(.table 6). Mamun(46) in his study showed that the mean age of the patients 
with upper gastrointestinal haemorrhage was 35.65 years and 49.40 years for 
duodenal ulcer and gastric ulcer respectively. Islam(19) found that the mean age 
incidence of duodenal ulcer was 38.4 years and gastric ulcer 47.0 years. Our 
findings in the current study were very similar to the above studies. 
 
In the current study male female ratio is 4 for bleeding peptic ulcer. This ratio 
was 7.5 & 3 for duodenal ulcer and gastric ulcer respectively (Table-7). These 
findings are similar to those of Mamun(46).Alam(47) and Miah(48 )found male to 
female ratio of hematemesis and malena 6.6, 7.5 and 7.3 respectively . 
Zimmerman et.al (49) also found male preponderance among the bleeders. This 
increased incidence of the ratio in our country reflects that males are more 
sufferers. 
 
The ratio of bleeding duodenal ulcer to gastric ulcer was 2.13(Table-6) in the 
present study. Alam47Mamun46 and Miah48 found the ratio 5.7, 11.66 and 3.5 
respectively. Ratio of bleeding between DU to GU in the western countries 
varies from 0.8 to 1.2 only. The reason for the higher proportion of the duodenal 
ulcer to gastric ulcer bleeding in our country than that of the western countries 
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may be due to geographical and racial variation as well as poor health care 
facilities. (50) 
 
Peptic ulcer is the commonest cause of hematemesis and malena. (51) The 
majority of such ulcers are found in the duodenum. Peptic ulcer disease is 
responsible for approximately half of all hospital admission with upper 
gastrointestinal haemorrhage in the western countries. In the present study 
peptic ulcer disease is the commonest cause of hematemesis & malena and 
comprises 50% and duodenal ulcer contributes to 34% of all cases and gastric 
ulcer is 16%. Saowaros at all in a study of endoscopic review of 5000 patients 
with upper GI haemorrhage in Thailand it was found 51.24% of causes were 
due to peptic ulcer disease. Zimmermair at al, (49) in Jerusalem, in a study found 
39.5% duodenal ulcer and 16.9% gastric ulcer. Alam (47) in his study showed 
PUD responsible for 50% for hematemesis & 58% was the leading causes of 
upper GI haemorrhage which is similar to the study of Mamun(46) and Alam(47) 
 
Variceal bleeding is an important cause of upper GI haemorrhage. In our 
present study 20% cases (Table-6) were due to variceal bleeding. It was similar 
to the findings of Alam(47),  Miah(48) ,Mamun(46) and Zimmennun in 
Jerusalem(49),  In USA it is similar to our study (20%).Erosive gastritis is an 
important cause of upper GI haemorrhage. It is implicated in up to 20% of cases 
of acute upper GI bleeding with an over all mortality of 10%. Mamun(46), in his 
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study, found 16% cases of upper GI hemorrhage was due to gastric erosion 
which was similar to those of Alam47 & Zimmerman et al49; whereas Miah 48 in 
his study found only 10%..in our study it was about 10% similar  to that of 
Miah48 and Alam47 but dissimilar to those of Mamun46 and Alam47. This may be 
due to small number of study population in this study. If the study would done 
in a large scale this picture could have been changed. Again may be due to 
intake, of newer NSAIDs and are less irritant to the gastric mucosa and increase 
consciousness need among both urban and ruler people about adverse effect of 
NSAIDs. The source of bleeding could not be detected at endoscopy in 3 (6%) 
cases. Mamun46Miah48 and Alam47 were unable to detect the source of bleeding 
in: 3(4%) 4(8%) and 3(6%) cases respectively. 
 
In the miscellaneous group of this study GIT malignancy contributes 5 (10%) of 
Cases with hematemesis and malena which is similar to the study of Miah48 and 
Alam49. In this group we had 2(4%) case of oesophagitis, 1(2%) cases of 
Mallory weis tear,1(2%) esophageal carcinoma,2(4%) gastric carcinoma1(2%) 
telangiectasia, which is similar to that of Miah48 & Alam47 Correlation  of  
upper GI bleed with smoking was found 11(65%),4(50%),1(25%) cases of  
duodenal ulcer,gastric ulcer, erosive gastritis respectively., Mamun46,alam 47 
and Miah48 found 40%, 45.83% and 76% cases with duodenal ulcer respectively 
and 66.6%, 40% and 80% cases with gastric ulcer respectively. Our findings 
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were similar to those of Alam47 and Mamun46. Islam, 19 found 50% and 50% of 
patients associated with smoking for DU and GU respectively. 
 
Intake of ulcerogenic drugs especially aspirin and other NSAIDs assumed to 
cause peptic ulceration in 15-25% of patients 52 and were associated with 
relative risk for ulcer bleeding of up to 5 fold. Chalmers et.a’l,53 in their met 
analysis recorded that the incidence of upper Gl bleeding was three times more 
common in patients taking NSAIDs, than in the control group. Up to 22% of 
bleeding episodes may be due to these drugs with a mortality of 10%. (54)  
NSAIDs were found 8(47%), 3(38%), 4(80%) of duodenal ulcer, gastric ulcer, 
erosive gastritis respectively. 
 
Miah (48) in his study showed 25% of gastric ulcer and 75% of cases of erosive 
gastritis with upper GI haemorrhage had history of taking NSAIDs. Alam(47) in 
his study has shown that upper GI bleeding due to erosive gastritis occurred 
after exposure to aspirin and other NSAIDs were 60% of the patients. These 
findings are similar to our finding regarding with erosive gastritis. In our series 
we found 6(12%) history of taking steroid in patients with upper GI 
haemorrhage. In these study group rural population (64%) suffered upper GI 
bleed more common than the urban population(36%).which is similar to Alam 
47
 which was about 58%. 
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In respect of ABO blood group system, As a whole patient with “O” blood 
group suffered more  22(44%) from hematemesis & malena with especially due 
to duodenal ulcer (47%). This findings is similar to those of Mamun46, 
Alam47 Miah48 and Alam47 who found 39.1% 57.1% 61.5% and 60% 
respectively of patients with DU bleeders had blood group “O”. 
 
In this study, hematemesis, malena and both hematemesis and malena were the 
presenting features of 30%, 18% and 52% of the patients. Among them 4(24%) 
patients of DU, 3 (38%) patients of GU & 4 (40%) patients of oesophageal 
varices presented with hematemesis and 3 (17%) patients of DU 1 (13%) 
patients of GU & 2 (20%) patients of oesophageal varices presented with 
malena 10 (59%) patients of DU presented with hematemesis and 
malena.(Table.10) 
 
Miah 48 in his study found 15.3% of DU, 25% of gastric ulcer and 37.0% of 
oesophageal varices group had history of hematemesis and malena. Alam47 in 
his study found 15% of DU and 37.5% of variceal bleeding. our findings 
regarding duodenal ulcer and variceal bleeders are similar to that Miah48 and 
Alam47. 
 
Miah48 showed DU patients presented with both hematemesis and malena in 
46.3% cases, malena in 38.4%, and hematemesis in 15% cases. Alam47 showed 
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that DU patients presented with hematemesis in 17.1 %cases, malena in 31.4% 
cases and both haemeaemesis and malena in 51.1% cases. Bleeding gastric ulcer 
& oesophageal varices presented equally 33.3% with both hematemesis and 
malena. Variation in presentation in cases of upper GI haemorrhage different 
studies maybe explained by the fact that haemetemesis and malena is dependent 
upon the rate, amount and site of bleeding,  
 
Anemia, epigastric tenderness, splenomegaly were found in 74%, 60% and 18% 
cases respectively 
 
Epigastric tenderness was present in 60% of patients of this series; it is a 
significant physical finding in active peptic ulcer disease. Miah48 found 
epigastric tenderness in 70% of cases. Alam47 found epigastric tenderness in 
76.6% of cases. Our finding is similar to that of Miah and Alam. 
 
Splenomegaly was present in all cases (80%) of variceal bleeding. Stigmata of 
chronic liver disease with splenomegaly helps in diagnosing a case of cirrhosis 
clinically. Splenomegaly is the most consistent finding of the patients presented 
with variceal bleeding. Splenomegaly is also a feature of haematological 
malignancy. 
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Nasogastric aspiration shows 86% of the patients having fresh or coffee ground 
colour of aspirated material which is suggestive for hematemesis. (Table 14) 
which is similar to the findings of other studies 47‘48. Haemoglobin percentage 
does not change immediately after hematemesis and malena. It usually takes 48 
hours for haemodilution to occur. In our series the mean Hb% was 7.50gm/dl. 
Rock all score was calculated and interpreted majority of patients 27(54%)were 
in the medium risk category .of which 4(40%), 16(59%), 13(100%) of patients 
belonging to low risk, medium risk ,high risk groups required blood 
transfusion.1(10%), 7(26%), 3(23%) of low risk, medium risk, high risk groups 
had rebleeding. 
 
During the hospital stay, 1(5.9%), 1(2.5%), 3(30%) of duodenal ulcer, gastric 
ulcer and esophageal varices developed recurrent bleed. 
 
Kaniz 54 in a retrospective study of 126 to 1996 in Holy Family Red Crescent 
Hospital, Dhaka, found recurrent bleeding in 19.04% cases. Our finding has 
similarity with that of Kaniz54. Study in UK is also has similarity to our study66. 
Hematemesis and malena result from various pathological conditions such as 
peptic ulcer, erosive gastrodudenitis, oesophagitis, oesophgeal varices, ca-
stomach ca-oesophgus & blood dscrasias. A single therapeutic modality should 
not consistently reduce bleeding from such an array on selected subgroup of 
patients such as portal hypertensive naturopathy. Drug treatment may 
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significantly reduce mortality and morbidity. In our present series we used H2 
receptor antagonist routinely in all variceal bleeding 10 patients although there 
is no controlled evidence of benefit of use of H2 receptor antagonist or antacid 
in variceal bleeding though they are used to prevent bleeding from stress 
induced acute mucosal ulcer. 
  
In managing the cases with hematemesis and malaena 65 patients (65%) were 
treated with 37 patients (74%) were treated with proton pump inhibitor (e.g. 
pantoprazole). Among the clinically suspected oesophageal varices patients two 
were treated with vasopressin and twelve were treated with octreotide, 9 were 
treated with banding. Among the endoscopically diagnosed ulcer bleeders 10 
were treated with sclerotherapy. 
 
The H2 receptor antagonist drugs block the production of acid by the parietal 
cells and heal 60-90% of duodenal ulcer over 4to 8 weeks with compared with 
35-45% with placebo plus antacid as required for relief of pain55   
 
Patients with hematemesis and malena need blood transfusion for resuscitation. 
Patients need blood transfusion until their vital signs are stable, bleeding ceases 
and enough red cells in circulation to provide adequate oxygenation54 .In the 
present study highest blood transfusion was needed in the variceal group(4.50 
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unit) followed by duodenal ulcer (3.5 unit). This finding is similar to theta of 
Miah48, Alam47. 
 
Mean hospital stay of duodenal ulcer was 5 days, gastric ulcer was 4 days and 
for esophageal varices was 9 days. 
 
Overall Mortality due to Upper GI Bleed is 4% of which duodenal ulcer had  
1(5.9%) , esophageal varices had1(10%) mortality rate. Miah48 found that the 
mortality was only 6%. 
 
The high rate of mortality from variceal bleeding may be due is the advanced 
stage of cirrhosis of liver and development of complications such as hepatic 
encephalopathy, renal failure, rebleeding and hepatocellular carcinoma etc. The 
mortality from DU diseases is due to having co-morbid conditions. It might also 
be that most of the patients admitted to hospital were from average and por 
socioeconomic group who were unable to bear the cost of medicine & blood 
transfusion. 
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Patients presenting with upper GI Bleeding in Government Mohan 
Kumaramangalam Medical College Hospital Salem, from December 2011 to 
November 2013, were studied.  
 
Duodenal ulcer was the commonest cause of hematemesis and malena followed 
by oesophageal varices, gastric ulcer, erosive gastritis and reflux oesophagitis.  
 
The peak incidence was among 35 to 45 years of age. Males were more  
predominant than female with male: female ratio.4:1 
 
“O” blood group was commoner among the total cases of hematemesis and 
malena and it was also commoner among the duodenal ulcer bleeders.  
 
Past history of epigastria pain was noted 15 (88%) and 6 (75%) cases of 
duodenal ulcer and gastric ulcer patients respectively. Past history of jaundice 
was obtained in 8 (80%) cases with oesophageal varices. Past history of 
hematemesis and malena was obtained in 2 (12%) & 3 (30%) cases of duodenal 
ulcer and oesophagcal varices. 
 
Hematemesis ,malena and both hematemesis and malena were the presenting 
features of 30%,18%,and 52% of the patients .Among them 4(24%) patients of 
DU, 3 (38%) patients of GU & 4 (40%) patients of oesophageal varices 
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presented with hematemesis and 3 (17%) patients of DU 1 (13%) patients of 
GU & 2 (20%) patients of oesophageal varices presented with malena 10 (59%) 
patients of DU presented with hematemesis and malena. 
 
Past history of epigastria pain was noted 15 (88%) and 6 (75%) cases of 
duodenal ulcer and gastric ulcer patients respectively. Past history of jaundice 
was obtained in 8 (80%) cases with oesophageal varices. Past history of 
hematemesis and malena was obtained in 2 (12%) & 3 (30%) cases of duodenal 
ulcer and oesophagcal varices. 
 
Anemia, epigastric tenderness, splenomegaly were found in 74%, 60% and 18% 
cases respectively  
 
In managing the cases with hematemesis and malena 65 patients (65%) were 
treated with 37 patients (74%) were treated with proton pump inhibitor (e.g. 
pantoprazole). Among the clinically suspected oesophageal varices patients two 
were treated with vasopressin and twelve were treated with octreotide, 9 were 
treated with banding.. Among the endoscopically diagnosed ulcer bleeders 10 
were treated with sclerotherapy. 
 
During the hospital stay, 1(5.9%), 1(2.5%), 3(30%) of duodenal ulcer, gastric 
ulcer and esophageal varices developed recurrent bleed. 
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Hematemesis and malena is a common medical emergency which needs 
immediate medical attention. Often it is very difficult to identify the underlying 
causes of hematemesis and malena. 
 
Our study, done in Government Mohan Kumaramangalam Medical College 
Hospital, Salem; revealed results comparable with studies done in other parts of 
this country. 
 
Peptic ulcer is the commonest cause of upper GI haemorrhage and the majority 
of the ulcers are located in the duodenum. Other common causes of 
hematemesis and malena are ruptured oesophageal varices and erosive gastritis. 
Sex and blood group distribution are almost similar with other studies 
conducted at home and abroad. But age distribution varies from country to 
country and it is a little bit lower in countries like us than those of western 
countries. 
 
Endoscopic examination is the most important diagnostic tool in the diagnosis 
as well as management of upper GI haemorrhage. 
 
Death due to hematemesis and malena is still a challenge for the investigators to 
modify treatment modalities to improve the prognosis. 
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Pitt falls 
1.A large scale study is needed to reveal the actual situation regarding aetiology, 
prompt management to reach a favourable outcome in our locality. 
2. Most of the patients presented very late after the development of symptoms, 
that could have influenced in tresult of our study 
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ANNEXURE 1 
PROFORMA 
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DISSERTATION ON UPPER GASTRO INTESTINAL BLEEDING 
PROFORMA 
Patient Details 
Name:                AGE:  SEX:   M  /  F 
Address: 
 
 
Occupation: 
I.P. No: 
DOA: DOD: 
 
History 
Hematemesis / Malena 
Onset: 
No. of Episodes: 
H/O Bleeding from Gums / Nose: 
H/O Dysphagia / Odynophagia: 
Anorexia / weight loss: 
H/O drug intake: 
۝ NSAID 
۝ ASPIRIN 
۝ ANTICOAGULA
NTS 
۝ STEROIDS 
۝ ANY OTHERS: 
H/O Bleeding PR: 
H/O Jaundice: 
H/O Passing clots in stool: 
H/O forceful vomiting/retching: 
  
Past History 
H/O Peptic Ulcer: 
Chronic Liver Disease: 
Bleeding disorder: 
Prev H/O: 
۝ SHT 
۝ DM 
۝ Bronchial Asthma: 
۝ Coronary Artery Disease: 
۝ Prev H/O Surgeries: 
 
Personal History 
Diet: 
۝ Smoker ۝ Alcoholic 
Family H/O: 
۝ Hematemesis ۝ G.I. Malignancy ۝ Bleeding disorders
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General Examination  
Built: 
Nourishment: 
۝ Consciousness 
۝ Oriented 
۝ Hydration 
۝ Pallor 
۝ Icterus 
۝ Cyanosis 
۝ Clubbing 
۝ Lymphadenopathy 
۝ Pedal Edema 
Any signs of Liver Failure: 
Oral Cavity 
Skin Patechae/ Telangiectasias 
VITALS 
Pulse: 
Blood pressure: 
SPO2: 
Temperature: 
Respiratory Rate: 
Hourly Urine Output: 
CVS: 
RS: 
CNS: 
 
Ryles Tube aspirate
۝ Active Blood ۝ Altered Blood ۝ No Bleed 
 
ATLS Shock Category 
Stage:  ۝ I ۝ II ۝ III ۝ IV 
 
Per Abdomen 
 
 
Per Rectal 
 
WORK UP 
Blood Grouping & Typing : 
Haemoglobin   : 
PCV    : 
Differential count           N:  L: 
Platelet Count   : 
Blood Sugar  : 
Blood Urea  : 
SR. Creatinine  : 
Na+    : 
K+   : 
 
URINE ANALYSIS 
Albumin   : 
Casts    : 
RBCS  : 
Bile Salts/Pigments : 
 
LIVER FUNCTION TESTS 
Bilirubin –  T  : 
  D  : 
SGOT    : 
SGPT    : 
ALP   : 
Protein –      Albumin : 
         Globulin : 
         Total : 
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COAGULATION PROFILE 
BT    : 
CT    : 
PT   : 
INR   : 
 
SEROLOGY 
HIV 1   : 
HIV 2   : 
HBS Ag  : 
Anti HCV  : 
 
ECG: 
Echo: 
X-Ray Chest PA View: 
X-Ray Abdomen Erect View: 
 
 
INITIAL MANAGEMENT 
 
 
 
 
 
 
PROVISIONAL DIAGNOSIS 
 
 
ULTRA SONOGRAM ABDOMEN 
Liver: 
Spleen: 
Portal Vein: 
Free Fluids
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Any Other Findings: 
 
CECT Abdomen (IF TAKEN) 
 
 
 
UPPER GI ENDOSCOPY 
 
 
FINAL DIAGNOSIS: 
 
 
TREATMENT DETAILS 
 
 
 
Condition on Discharge: 
 
Follow Up: 
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ANNEXURE 2 
PATIENT CONSENT FORM 
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PATIENT’S CONSENT FOR THE STUDY 
 
 I confirm that I have understood the purpose of surgical procedure for the above 
study. I have the opportunity to ask the question and all my questions and doubts have been 
answered to my satisfaction. 
 I have been explained about the possible complications that may occur during surgical 
and post surgical procedure. I understand that my participation in the study is voluntary and 
that I am free to withdraw at any time without giving any reason. 
 I understand that investigator, regulatory authorities and ethics committee will not 
need my permission to look at my health records both in respect to current study and any 
further  research that may be conducted in relations to it, even if I withdraw from the study. I 
understand that my identity will not be revealed in any information released to third party or 
published unless as required under law. I agree not to restrict the use of any data or results 
that arise from the study. 
 I hereby consent to participate in this study for various surgical procedures and their 
outcomes. I understood everything written above in my vernacular language and has signed 
below with my conscious consent. 
 
Time : ……………………………… 
Date: ………………………….......... 
Place: SALEM.        Signature/ thumb impression of the patient 
Signature of the investigator:…………………………………………… 
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ANNEXURE 3 
MASTER CHART 
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PLATE 1 
 
 
 
 
 
 
 
 
 
BLEEDING DUODENAL ULCER 
 
 
 
 
 
 
 
 
 
ESOPHAGITIS 
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PLATE 2 
 
 
 
 
 
 
 
 
 
ESOPHAGEAL VARICES 
 
 
 
 
 
 
 
 
 
 
 
CARCINOMA STOMACH 
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           PLATE 3 
 
 
 
 
 
 
 
 
 
 SCLEROTHERAPY 
 
 
 
 
 
 
 
 
 
 
 
 BANDING 
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